Want to join the conversation?
Mark Schoenebaum of Evercore ISI asks what is $AMGN's appetite for an at-risk Humira biosimilar launch. CEO Bob Bradway said the company is not going to comment on its launch plans for Humira. He added that the next step is for $AMGN to get a regulatory approval for its molecule and that is what the company is focused on securing.
$AAL is giving pay hikes to its employees but investors are sulking.
$APC stock tumbled more than 5.6% after last week's fatal home explosion in Firestone, Colorado prompted the company to close more than 3,000 wells for weeks.
Unicorn Frappuccino. The latest hit from $SBUX. Can't wait to see how this will affect its results.
At what point should $AMZN consider a stock split? $1000 per share seems pretty high.